Cancer Institute A national cancer institute
designated cancer center

Ellen Chang

Publication Details

  • Serum YKL-40 and interleukin 6 levels in Hodgkin lymphoma.

    Biggar RJ, Johansen JS, Smedby KE, Rostgaard K, Chang ET, Adami HO, Glimelius B, Molin D, Hamilton-Dutoit S, Melbye M, Hjalgrim H. Clin Cancer Res. 2008; 14 (21): 6974-8

    Serum levels of the inflammatory markers YKL-40 and interleukin 6 (IL-6) are increased in many conditions, including cancers. We examined serum YKL-40 and IL-6 levels in patients with Hodgkin lymphoma, a tumor with strong immunologic reaction to relatively few tumor cells, especially in nodular sclerosis Hodgkin lymphoma.

    PubMedID: 18980992

Stanford Medicine Resources:

Footer Links: